Juan Kurdi
Interventional Cardiology · Lubbock, TXNPI 1568429504
Payments from drug & device makers
Across 505 payments — averaging $381.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$183K
- Abbott$2K
- Medtronic$2K
- Boston Scientific$2K
- Johnson & Johnson$530
- Novartis$455
- plus $3K from 30 others
What the payments were for
- Food & beverage$10,3675%
- Education$26,89414%
- Other$155,25081%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 11 | $182,949 |
| Abbott | 79 | $2,168 |
| Medtronic(2 entities) | 119 | $1,886 |
| Boston Scientific | 88 | $1,766 |
| Johnson & Johnson | 35 | $530 |
| Novartis | 22 | $455 |
| Pfizer | 31 | $362 |
| AstraZeneca | 16 | $328 |
| Amgen | 20 | $237 |
| Sanofi-aventis U.S. LLC | 13 | $203 |
| Boehringer Ingelheim | 9 | $144 |
| W. L. Gore & Associates, Inc. | 2 | $131 |
| Cvrx, Inc. | 1 | $131 |
| Actelion Pharmaceuticals US, Inc. | 4 | $117 |
| Merck | 8 | $115 |
| Nuwellis, Inc. | 1 | $113 |
| Novo Nordisk | 4 | $88 |
| Endologix LLC | 1 | $86 |
| Bayer | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 3 | $71 |
| Gilead | 4 | $51 |
| Lexicon Pharmaceuticals, Inc. | 3 | $50 |
| Cardiovascular Systems Inc. | 4 | $50 |
| Cardinal Health 200 LLC | 3 | $49 |
| Cordis US CORP. | 2 | $48 |
| Tactile Systems Technology Inc | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $27 |
| Astellas Pharma US Inc | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $19 |
| Philips North America LLC | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$182,826
- Xience Sierra Coronary Stent$221
- ENSITE PRECISION$140
- IN.PACT Admiral$133
- Barostim Neo System$131
- VIABAHN VBX Balloon Expandable Endoprosthesis$119
- Aquadex$113
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$112
- Xience Alpine cornary stent system$105
- Supera peripheral stent system$102
How this compares
$192,511 in reported general payments places this provider in the 90th percentile of 686 interventional cardiology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 132 | $111,074 |
| EliquisApixaban | 107 | $106,177 |
| EntrestoSacubitril/Valsartan | 61 | $53,987 |
| Repatha SureclickEvolocumab | 39 | $26,944 |
| BrilintaTicagrelor | 32 | $19,688 |
| Praluent PenAlirocumab | 23 | $11,860 |
| ClopidogrelClopidogrel Bisulfate | 521 | $5,278 |
| LivaloPitavastatin Calcium | 11 | $4,545 |
| Metoprolol Succinate | 267 | $4,021 |
| Atorvastatin Calcium | 278 | $2,207 |
| Potassium Chloride | 74 | $1,191 |
| Amiodarone Hcl | 52 | $991 |
| Ranolazine ErRanolazine | 22 | $892 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $874 |
| Losartan Potassium | 85 | $850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $530 | $111,074132 claims |
| PfizerEliquis | $362 | $106,177107 claims |
| NovartisEntresto | $455 | $53,98761 claims |
| AstraZenecaBrilinta | $328 | $19,68832 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 686 interventional cardiology providers in Texas.
Other interventional cardiology in Lubbock
- Mohammad AnsariLubbock$961K
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Ira LieberKingwood$3.3M
- Cara Ann EastDallas$3M
- Abhijeet DhobleHouston$2.7M
- Jeffrey CarrTyler$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.